Literature DB >> 20613906

Proliferation of CD4CD25Foxp3 regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma.

Yong Wook Jung1, Seok Ju Seong, Chong Taik Park.   

Abstract

Entities:  

Year:  2010        PMID： 20613906      PMCID： PMC2895714          DOI： 10.3802/jgo.2010.21.2.132

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN： 2005-0380            Impact factor:   4.401


× No keyword cloud information.
  6 in total

Review 1.  Cancer despite immunosurveillance: immunoselection and immunosubversion.

Authors:  Laurence Zitvogel; Antoine Tesniere; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2006-09-15       Impact factor: 53.106

2.  Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

Authors:  Pierpaolo Correale; Maria Saveria Rotundo; Maria Teresa Del Vecchio; Cinzia Remondo; Cristina Migali; Chiara Ginanneschi; Kwong Y Tsang; Antonella Licchetta; Susanna Mannucci; Lucia Loiacono; Pierfrancesco Tassone; Guido Francini; Pierosandro Tagliaferri
Journal:  J Immunother       Date:  2010-05       Impact factor: 4.456

3.  Proliferation of CD4CD25Foxp3 regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma.

Authors:  Shin Wha Lee; Yong-Man Kim; Ha-Young Lee; Dae-Yeon Kim; Jong-Hyeok Kim; Joo-Hyun Nam; Young-Tak Kim
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

4.  Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype.

Authors:  Jason C Barnett; Sarah M Bean; Regina S Whitaker; Eiji Kondoh; Tsukasa Baba; Shingo Fujii; Jeffrey R Marks; Holly K Dressman; Susan K Murphy; Andrew Berchuck
Journal:  Gynecol Oncol       Date:  2009-12-14       Impact factor: 5.482

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer.

Authors:  Tomoyuki Aruga; Eiji Suzuki; Shigehira Saji; Shin-Ichirou Horiguchi; Kazumi Horiguchi; Susumu Sekine; Dai Kitagawa; Nobuaki Funata; Masakazu Toi; Kenichi Sugihara; Katsumasa Kuroi
Journal:  Oncol Rep       Date:  2009-08       Impact factor: 3.906
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.